Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers December 15, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - December 15, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/15/18 - BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1 A/1B trial of tislelizumab, an investigational anti-PD-1 antibody, were presented in an oral...
12/15/18 - Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO [Tehran Times (Iran)]
-Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported safety and promising activity of BPX-601 in Part 1 of a Phase 1/ 2 dose-escalation study in patients with advanced, metastatic pancreatic cancer expressing PSCA. Data were reviewed dur
12/15/18 - Bovine Blood Plasma Derivatives Market Will Increment at a Notable CAGR of 5.8% During the Forecast Period of 2017 to 2025
Albany, NY 12/14/2018 Global Bovine Blood Plasma Derivatives Market: Snapshot. Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. The analysts of the report have evaluat
12/15/18 - Butantan Institute and MSD agree to collaborate on dengue vaccine development [T-break Tech (Middle East)]
Brazil`s Butantan Institute signed a collaboration agreement with Merck Sharp& Dohme to develop dengue vaccines. The vaccine developed by Butantan Institute with So Paulo Research Foundation- FAPESP`s support is currently in the last phase of trials involving humans, with 17,000 volunteers participating. The agreement also allows for exclusive...
12/15/18 - Dr. Jin Kim, Internationally Influential Periodontist, Offers FDA-Cleared LANAP Laser Therapy for Periodontal Disease in Chino Hills, CA [Tehran Times (Iran)]
-Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal care welcomes people withperiodontal diseasein Chino Hills, CA, to take advantage of LANAP, the FDA- cleared laser gum therapy treatment he offers. When patients work with Dr. Kim to properly address their gum d
12/15/18 - Family of Lakewood toddler with brain tumor desperate for unapproved drug []
LAKEWOOD, Colo. 2018 Elijah Gonzalez can only eat through a feeding tube. "The only drug that could really help him save his live is called tazemetostat manufactured by Epizyme," said Elijah's father Cesar Gonzalez. Yet the 41- year old Lakewood dad said the Massachusetts- based pharmaceutical company Epizyme has not been willing to make its exp
12/15/18 - Greens, beans and dark chocolate to boost vitamin D
PEOPLE should eat dark, leafy greens and dark chocolate as well as taking supplements to get the proper dose of the sunshine vitamin D during the dark winter months, scientists say. Scotland has the lowest levels of vitamin D, due to a lack of sunshine and a diet low in oily fish. Research professor, Dr Martha Shrubsole, at Vanderbilt University Me
12/15/18 - Injectable Drug Delivery Market: In-Depth Evaluation on Growth, Share, Size and Trends Until the End of 20182028: Drug delivery refers to the approaches, technologies and systems used for the administration of drugs to patients.
Albany, NY 12/15/2018 In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine has included a new report titled " Injectable Drug Delivery Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to tr
12/15/18 - KalVista Pharmaceuticals Reports Fiscal Second Quarter Results [Daily Tribune (Bahrain)]
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today provided an operational update and released financial results for the fiscal second quarter ended October 31, 2018. We are still on track with our robust Phase 2 study for
12/15/18 - Magnesium Lactate Market Value Chain and Forecast 2018-2026
Rockville, MD 12/14/2018 Magnesium Lactate Market Introduction:. Magnesium lactate is a magnesium salt of lactic acid and commonly used ingredient added to food and beverages as an acidity regulator. It is also used as a dietary supplement and as a nutrient in different formulation.
12/15/18 - On Senate Floor, Portman Highlights How PSI Investigative Report Resulted in Lower Prices for Opioid Overdose Reversal Drug
Last night, U.S. Senator Rob Portman delivered remarks on the Senate floor about the bipartisan Permanent Subcommittee on Investigations report, which was highlighted on 60 Minutes, that found the drug manufacturer kaleo increased the price of its opioid overdose reversal drug by more than 600 percent to "capitalize on the opportunity" of "opioid o
12/15/18 - Orbital ATK, EpicentRx Assigned Patent for Cyclic Nitro Compounds
Orbital ATK, Dulles, Virginia, and EpicentRx, La Jolla, California, have been assigned a patent developed by seven co-inventors for "cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof." The co-inventors are Mark D. Bednarski, Los Altos, California, Susan Knox, Stanford, California, Louis Cannizzo, Ogden, Utah, Kirstin Warn
12/15/18 - Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency [Tehran Times (Iran)]
-Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, and SIRION Biotech GmbH today announced the entry into a license agreement, pursuant to which Orchard has licensed SIRIONs LentiBOOST...
12/15/18 - Prefilled Syringe Contract Manufacturing Market: Growth, Demand and Key Players to 2028
New York, NY 12/15/2018 Prefilled Syringe Contract Manufacturing Market: Introduction. Prefilled syringes is an important innovations by pharmaceutical industries to provide new vision for syringe medication which provide a new growth opportunities. Prefilled syringes are prospects for patients who are under treatment and need drug administra
12/15/18 - Ridgefield pharma continues chase of blockbuster drug alone [The Hour, Norwalk, Conn.]
Boehringer Ingelheim Pharmaceuticals intends to find out and the Ridgefield giant is not following the script of its competitors. "Boehringer Ingelheim believes the introduction of high-quality, lower-cost biosimilars is critical for both patients and the sustainability of the system," stated Susan Holz, a Boehringer Ingelheim spokesperson in...
12/15/18 - Sonoma Pharmaceuticals Announces Management Changes [Tehran Times (Iran)]
-Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today announced a series of management changes. Mr. Sandford, 57, has over 30 years of experience leading companies in several industries and at various s
12/15/18 - Takeda Receives Positive CHMP Opinion for ADCETRIS for the Treatment of Adult Patients With Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination With AVD
-If Authorized in Europe, ADCETRIS in Combination with AVD Will Be the First New Treatment Regimen Available for Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Decades. Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a posi
12/15/18 - TrialSpark debuts first clinical trial sites as part of deal with Novartis [T-break Tech (Middle East)]
New York- based tech CRO TrialSpark launched its first clinical trial sites as part of a partnership with Novartis that takes a new direction. TrialSparks approach addresses issues with trial participants who dont live near large academic centers or hospital-based trial sites by allowing them to participate at their local doctors office.
12/15/18 - XenoTherapeutics Plans to Initiate Clinical Trials for a Pig-Skin Burn Treatment [Syrian Arab News Agency]
But for Boston- based XenoTherapeutics, pigskin means a potential treatment option for burn victims. Earlier this week, the U.S. Food and Drug Administration cleared the companys Investigational New Drug Application to allow the company to initiate clinical studies with Xeno-Skin, a product designed to provide help for patients who have suffered fr
12/14/18 - 2018 Alabama Health Care Year in Review
I have written this top ten list for years and each time I "try" to write an introduction that is funny or which contains a quote that is uplifting and appropriate for the current year. That is what unites Alabama healthcare providers. I am reminded of this when I read about the citizens of Sumter and Chilton Counties who passed a sales tax to keep
12/14/18 - 2018 Developments in Aquaponics, Nutritive Supplements, Carbon Capture and Biobricks -
The "Recent Developments in Aquaponics, Nutritive Supplements, Carbon Capture, and Biobricks" report has been added to' s offering. Antarctic Krill-based Nutritive Supplements for Animals and Humans Patented Carbon Capture Technologies for Coal-based Power Plants Modular and Scalable Indoor Aquaponic Farms with More Food...
12/14/18 - DRUG$ to Begin L.A. Theatrical Run at Laemmle Music Hall 3 in Beverly Hills Dec.14th
DRUG$, a new documentrary that explores the mystery of modern medicine s skyrocketing price tag here in the U.S. and how it affects people struggling to stay alive, begins a weeklong theatrical run in Los Angeles at the Laemmle Music Hall 3 in Beverly Hills starting Friday, December 14 th. About AIDS Healthcare Foundation and why we produc
12/14/18 - Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl [Tehran Times (Iran)]
-Adial Pharmaceuticals, Inc.,, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced plans to expand activities around the Companys lead asset, AD04, beyond alcohol use disorder, to now include its potential use in patients with opioid use disorder. William Stilley, CEO
12/14/18 - AGTC Slumps After-hrs, NBIX Fails To Strike GOLD, IDRA To Report Data On Dec.14 [Sudan Tribune]
Today`s Daily Dose brings you news about disappointing trial results of Applied Genetic Technologies; near-term catalyst of Idera; stock offering of Marinus; disappointing Tourette syndrome trial results of Neurocrine Biosciences; bankruptcy proceedings of Synergy Pharma; Complete Response Letter for Mallinckrodt`s pain drug, and promising data fro
12/14/18 - Alder BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Alder BioPharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today reported that the Compensation Committee of Alder s Board of Directors granted a non-qualified stock option to purchase an aggregate of 270,000 shares of Alder s common stock to Carlos E. Campoy
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement